Skip to main content
. 2019 Jun 8;220(7):1188–1198. doi: 10.1093/infdis/jiz269

Figure 7.

Figure 7.

Illustration of the P-glycoprotein (P-gp) interaction with bumped kinase inhibitors (BKIs) in the gastrointestinal tract. A, Low absorption of BKI1318 into the enterocyte as a result of P-gp–mediated efflux. B, In the presence of the P-gp inhibitor elacridar, BKI1318 absorption into the intestinal epithelium allows for targeting of Cryptosporidium.